1. Home
  2. ABVX vs RRBI Comparison

ABVX vs RRBI Comparison

Compare ABVX & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • RRBI
  • Stock Information
  • Founded
  • ABVX 2013
  • RRBI 1998
  • Country
  • ABVX France
  • RRBI United States
  • Employees
  • ABVX N/A
  • RRBI N/A
  • Industry
  • ABVX
  • RRBI Hotels/Resorts
  • Sector
  • ABVX
  • RRBI Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • RRBI Nasdaq
  • Market Cap
  • ABVX 511.3M
  • RRBI 406.6M
  • IPO Year
  • ABVX N/A
  • RRBI 2019
  • Fundamental
  • Price
  • ABVX $66.49
  • RRBI $61.00
  • Analyst Decision
  • ABVX Buy
  • RRBI Buy
  • Analyst Count
  • ABVX 7
  • RRBI 1
  • Target Price
  • ABVX $65.71
  • RRBI $62.00
  • AVG Volume (30 Days)
  • ABVX 2.8M
  • RRBI 19.4K
  • Earning Date
  • ABVX 08-11-2025
  • RRBI 08-05-2025
  • Dividend Yield
  • ABVX N/A
  • RRBI 0.79%
  • EPS Growth
  • ABVX N/A
  • RRBI 13.23
  • EPS
  • ABVX N/A
  • RRBI 5.31
  • Revenue
  • ABVX $11,444,012.00
  • RRBI $112,266,000.00
  • Revenue This Year
  • ABVX $284.20
  • RRBI $4.69
  • Revenue Next Year
  • ABVX N/A
  • RRBI $5.73
  • P/E Ratio
  • ABVX N/A
  • RRBI $11.49
  • Revenue Growth
  • ABVX 128.98
  • RRBI 6.50
  • 52 Week Low
  • ABVX $4.77
  • RRBI $46.33
  • 52 Week High
  • ABVX $72.90
  • RRBI $64.65
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 92.92
  • RRBI 48.17
  • Support Level
  • ABVX $9.96
  • RRBI $60.03
  • Resistance Level
  • ABVX $72.90
  • RRBI $63.80
  • Average True Range (ATR)
  • ABVX 1.84
  • RRBI 1.25
  • MACD
  • ABVX 6.88
  • RRBI -0.54
  • Stochastic Oscillator
  • ABVX 90.17
  • RRBI 21.08

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

Share on Social Networks: